当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析

易瑞生物

(300942)

  

流通市值:21.53亿  总市值:26.38亿
流通股本:3.27亿   总股本:4.01亿

易瑞生物(300942)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.99亿元,每股收益-0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益94835.88万元,未分配利润22419.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产147531.87万元,负债52695.99万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入165,099,285.79112,111,327.4960,707,585.25686,897,476.53
营业总成本244,638,062.81184,963,695.4894,325,423.68555,470,050.87
营业利润-95,086,336.81-83,792,972.32-33,534,213.8298,107,417.54
利润总额-96,238,802.25-83,995,058.61-33,443,386.3994,886,178.21
净利润-99,216,611.87-69,675,890.25-28,085,394.8482,663,795.37
其他综合收益1,803,253.062,622,166.4443,114.26189,564.33
综合收益总额-97,413,358.81-67,053,723.81-28,042,280.5882,853,359.7
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计822,383,647.31542,567,633.12571,749,100.26674,419,310.45
非流动资产合计652,935,011.81640,758,053.99631,158,729.22608,036,291.29
资产总计1,475,318,659.121,183,325,687.111,202,907,829.481,282,455,601.74
流动负债合计132,735,232.4145,305,756.38147,639,422.25199,783,500.79
非流动负债合计394,224,665.37140,857,299.53114,521,406.2117,970,958.09
负债合计526,959,897.77286,163,055.91262,160,828.45317,754,458.88
归属于母公司股东权益合计948,574,979.54897,364,388.97940,932,767.88964,891,208.73
股东权益合计948,358,761.35897,162,631.2940,747,001.03964,701,142.86
负债和股东权益合计1,475,318,659.121,183,325,687.111,202,907,829.481,282,455,601.74
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计202,566,641.66116,724,611.3364,945,294.39786,089,186.39
经营活动现金流出小计260,955,442.65188,492,983.83118,936,013.49633,534,654.42
经营活动产生的现金流量净额-58,388,800.99-71,768,372.5-53,990,719.1152,554,531.97
投资活动现金流入小计419,425,131.3311,380,328.77181,020,000873,625,986.2
投资活动现金流出小计329,997,753.53290,127,239.37157,057,315.231,063,573,588.75
投资活动产生的现金流量净额89,427,377.7721,253,089.423,962,684.77-189,947,602.55
筹资活动现金流入小计391,965,707.3248,331,552.251,192,83066,710,311.35
筹资活动现金流出小计26,428,470.4923,162,112.455,412,566.45120,558,007.11
筹资活动产生的现金流量净额365,537,236.8325,169,439.8-4,219,736.45-53,847,695.76
汇率变动对现金及现金等价物的影响4,794,538.887,260,250.03-1,135,290.77-809,008.1
现金及现金等价物净增加额401,370,352.49-18,085,593.27-35,383,061.55-92,049,774.44
期末现金及现金等价物余额648,551,039.12229,095,093.36211,797,625.08247,180,686.63
TOP↑